Therapeutic Targeting of SGLT2: A New Era in the Treatment of Diabetes and Diabetic Kidney Disease.

Shaffner, James; Chen, Bohan; Malhotra, Deepak K; Dworkin, Lance D; Gong, Rujun

Shaffner, James; Chen, Bohan; Malhotra, Deepak K; Dworkin, Lance D; Gong, Rujun.

Afiliação

Shaffner J; Department of Medicine, Division of Nephrology, University of Toledo College of Medicine, Toledo, OH, United States.
Chen B; Department of Medicine, Division of Nephrology, University of Toledo College of Medicine, Toledo, OH, United States.
Malhotra DK; Department of Medicine, Division of Nephrology, University of Toledo College of Medicine, Toledo, OH, United States.
Dworkin LD; Department of Medicine, Division of Nephrology, University of Toledo College of Medicine, Toledo, OH, United States.
Gong R; Department of Medicine, Division of Nephrology, University of Toledo College of Medicine, Toledo, OH, United States.

Front Endocrinol (Lausanne) ; 12: 749010, 2021.

Article em En | MEDLINE | ID: mdl-34790170

Assuntos

Diabetes Mellitus/tratamento farmacológico; Nefropatias Diabéticas/tratamento farmacológico; Hipoglicemiantes/uso terapêutico; Inibidores do Transportador 2 de Sódio-Glicose/uso terapêutico; Humanos

Palavras-chave

SGLT2; diabetes; diabetic kidney disease; glycosuria; ketosis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Nefropatias Diabéticas / Inibidores do Transportador 2 de Sódio-Glicose / Hipoglicemiantes Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google